Buspirone for Weak or Absent Esophageal Peristalsis

Summary

This is a randomized, double-blind, placebo-controlled, cross-over clinical trial of buspirone in patients with complaints of dysphagia due to poor esophageal motility. The goal of this clinical trial is to study the effect of buspirone on esophageal motility by performing high resolution impedance manometry (HRiM).

Timeline

Start

2021-07-06

Primary completion

2024-09-30

Completion

2024-09-30

Drugs

Indications